2015-07-19 19:17:11 UTC

Resear

May 19, 2015

The AGA Research Foundation awarded Juan Gonzalez-Abraldes the 2015 AGA-Elsevier Pilot Research Award, which he will use to better understand the pathophysiology of portal hypertension in cirrhosis. 

Specifically, Dr. Gonzalez-Abraldes will investigate the role of the gut derived metabolite propionate in the pathogenesis of portal hypertension. 

Dr. Gonzalez-Abraldes, who recently moved to North America, said he is very thankful to the AGA Research Foundation for the grant, which will be "instrumental" in moving forward on his research in portal hypertension. 

 

 

More on Cirrhosis

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis

Oct. 11, 2017

Statin use is probably associated with lower risk of hepatic decompensation and mortality, and might reduce portal hypertension, in patients with CLDs.

Cirrhosis Presenting as Cutaneous Calciphylaxis

Oct. 11, 2017

A 73-year-old woman with a history of hypertension presented with a 3-month history of a painful, non-healing right calf ulcer and 2–3 weeks of painful, dusky purple patches on the right thigh.